Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

The last several investor days have let downs, because nothing of value was delivered. They largely served as a podium for management to tell investors that they deserved more non-merit based compensation. If Berlin has nothing of value to deliver, better not to have an investor. He needs to be spending 100% of his time closing a large non dilutive monetary deal or outright sale of the company. For too long the compnay has been managed solely for the benefit of employees. We need alignment with the interest of the owners who foot the bills for a change.